Report from a consensus conference on primary graft dysfunction after cardiac transplantation
- PMID: 24661451
- DOI: 10.1016/j.healun.2014.02.027
Report from a consensus conference on primary graft dysfunction after cardiac transplantation
Abstract
Although primary graft dysfunction (PGD) is fairly common early after cardiac transplant, standardized schemes for diagnosis and treatment remain contentious. Most major cardiac transplant centers use different definitions and parameters of cardiac function. Thus, there is difficulty comparing published reports and no agreed protocol for management. A consensus conference was organized to better define, diagnose, and manage PGD. There were 71 participants (transplant cardiologists, surgeons, immunologists and pathologists), with vast clinical and published experience in PGD, representing 42 heart transplant centers worldwide. State-of-the-art PGD presentations occurred with subsequent breakout sessions planned in an attempt to reach consensus on various issues. Graft dysfunction will be classified into primary graft dysfunction (PGD) or secondary graft dysfunction where there is a discernible cause such as hyperacute rejection, pulmonary hypertension, or surgical complications. PGD must be diagnosed within 24 hours of completion of surgery. PGD is divided into PGD-left ventricle and PGD-right ventricle. PGD-left ventricle is categorized into mild, moderate, or severe grades depending on the level of cardiac function and the extent of inotrope and mechanical support required. Agreed risk factors for PGD include donor, recipient, and surgical procedural factors. Recommended management involves minimization of risk factors, gradual increase of inotropes, and use of mechanical circulatory support as needed. Retransplantation may be indicated if risk factors are minimal. With a standardized definition of PGD, there will be more consistent recognition of this phenomenon and treatment modalities will be more comparable. This should lead to better understanding of PGD and prevention/minimization of its adverse outcomes.
Keywords: cardiac transplantation; consensus; outcomes; primary graft dysfunction; primary graft failure.
Copyright © 2014 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.J Heart Lung Transplant. 2018 Dec;37(12):1433-1442. doi: 10.1016/j.healun.2018.07.013. Epub 2018 Jul 26. J Heart Lung Transplant. 2018. PMID: 30206023
-
Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition.Transplantation. 2015 Sep;99(9):1919-25. doi: 10.1097/TP.0000000000000620. Transplantation. 2015. PMID: 25742423 Free PMC article.
-
Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.Clin Transplant. 2019 May;33(5):e13538. doi: 10.1111/ctr.13538. Epub 2019 Apr 14. Clin Transplant. 2019. PMID: 30870577
-
Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system.J Heart Lung Transplant. 2007 May;26(5):431-6. doi: 10.1016/j.healun.2007.01.029. Epub 2007 Mar 21. J Heart Lung Transplant. 2007. PMID: 17449410 Review.
-
Primary graft dysfunction after liver transplantation.Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):125-37. doi: 10.1016/s1499-3872(14)60023-0. Hepatobiliary Pancreat Dis Int. 2014. PMID: 24686540 Review.
Cited by
-
Risk prediction models of primary graft dysfunction in cardiac transplant patients: a need to improve?Front Cardiovasc Med. 2024 Sep 23;11:1478821. doi: 10.3389/fcvm.2024.1478821. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39376622 Free PMC article. No abstract available.
-
Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time.Biomedicines. 2024 Sep 16;12(9):2109. doi: 10.3390/biomedicines12092109. Biomedicines. 2024. PMID: 39335622 Free PMC article.
-
The Utility of the Vasoactive-Inotropic Score and Its Nomogram in Guiding Postoperative Management in Heart Transplant Recipients.Transpl Int. 2024 Jul 25;37:11354. doi: 10.3389/ti.2024.11354. eCollection 2024. Transpl Int. 2024. PMID: 39119063 Free PMC article.
-
Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial.BMJ Open. 2024 Jun 13;14(6):e086777. doi: 10.1136/bmjopen-2024-086777. BMJ Open. 2024. PMID: 38871657 Free PMC article.
-
Sex and Gender-related Disparities in Clinical Characteristics and Outcomes in Heart Transplantation.Curr Heart Fail Rep. 2024 Aug;21(4):367-378. doi: 10.1007/s11897-024-00670-0. Epub 2024 Jun 11. Curr Heart Fail Rep. 2024. PMID: 38861129 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous